This is a routine disclosure of an insider share sale. No material read-through for the company's operations or outlook. Monitor for any pattern of increased insider selling in future filings.
NVO drugs
NVO drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 5 $40.30entry
- T+1 · 11d ago +0.02%α −0.29% · $40.31
- T+5 · 5d ago +0.87%α −2.42% · $40.65
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Novo Nordisk filed a Form 6-K disclosing a share sale by Executive Vice President and CSO Martin Holst Lange. He sold 12,000 B shares at DKK 285.00 per share, for a total of DKK 3,420,000. This is a routine insider sale disclosure with no material financial impact.
Key Facts
- Martin Holst Lange (EVP, R&D and CSO) sold 12,000 Novo Nordisk B shares
- Sale price: DKK 285.00 per share
- Total proceeds: DKK 3,420,000
- Transaction date: November 4, 2026
- Place of transaction: Nasdaq Copenhagen
Financial Impact
DKK 3.42 million insider sale by a single executive
Risk Factors
- No material risks identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-007156 |
| Document: 0001171843-26-007156-index-headers.html | 0001171843-26-007156 |
| Document: 0001171843-26-007156-index.html | 0001171843-26-007156 |
| Document: 0001171843-26-007156.txt | 0001171843-26-007156 |
| Earnings Context (Synthetic; results releases only) | 0001171843-26-007156 |
Track record
43 reports on NVO
5 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +23.56% at T+60 after the Jul 28, 2026 report. 6 of 7 went positive at some point.
Filters
- Nov 16, 2026today 6-K Neutral 2/10 Entry $41.89 Now $41.60 −0.69% settles Dec 15
- Nov 13, 20264d ago Court Ruling Neutral 3/10 Entry $42.01 Now $41.60 −0.98% settles Dec 15
- Nov 13, 20264d ago Court Ruling Neutral 1/10 Entry $42.01 Now $41.60 −0.98% settles Dec 15
- Nov 9, 20267d ago 6-K Neutral 2/10 Entry $41.38 Now $41.60 +0.53% settles Dec 8
- Nov 5, 202611d ago Institutional Cluster Neutral 2/10 Entry $40.30 Now $41.60 +3.23% settles Dec 4
- Nov 5, 202611d ago 6-K Neutral 2/10 Viewing Entry $40.30 Now $41.60 +3.23% settles Dec 4
- Nov 4, 202612d ago 6-K Bullish 6/10 Entry $42.18 Now $41.60 −1.38% settles Dec 3
- Nov 3, 202613d ago 6-K Neutral 2/10 Entry $40.19 Now $41.60 +3.51% settles Dec 2
- Oct 26, 202621d ago 6-K Neutral 2/10 Entry $39.13 Now $41.60 +6.31% settles Nov 23
- Oct 26, 202622d ago Court Ruling Neutral 4/10 Entry $38.67 Now $41.60 +7.58% settles Nov 24
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers